
Cerus wins regulatory approvals for next-gen blood safety device in France, Switzerland
Cerus Corp. announced that its next-generation blood safety device, the INT200, has received regulatory approvals from both the French National Agency for Medicines and Health Product Safety and the Swiss Agency for Therapeutic Products. The INT200 is a …